For Brain and Belly? New Science on GLP-1 for Alzheimer's
Nick Norwitz, MD, PhD — For Brain and Belly? New Science on GLP-1 for Alzheimer's
Channel: Nick Norwitz MD PhD · Our label: Physician-researcher educator · Source: youtube.com/watch?v=183PpRF4kgY
What this video covers
Could a hormone made famous by drugs like Ompic secretly help defend your brain against Alzheimer’s disease? New research that actually surprised me looks very encouraging. This represents the relationship between the hormone GLP1 circulating in the blood and levels of amalloid in the human brain. GLP-1 is that now famous weight loss hormone that drugs like OMPIC and WGOI try to mimic.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Lower GLP1 levels associate with more amaloid and higher GLP1 levels associate with less amaloid.
- And this is also consistent with other randomized controlled human trials, including those targeting cardiovascular outcomes and a 12 month phase 2 randomized control trial in adults with mild cognitive impairment.
- GLP-1 hormone or GLP1 receptor agonists bind to receptors in the brain.
- GLP-1 and GLP-1 receptor agonist they decrease neuroinflammation.
- Or mental health, we can fix the problem by addressing the root cause, metabolic health.
- A health-promoting compound found in coffee and yerba mate tea called chlorogenic acid can activate a signaling pathway called the NRF2 pathway in the brain that can reduce neuroinflammation and support brain health.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.